Indeed, results from a large pan-cancer WGS study include ATM among the top 26 driver genes in these cancers, being found altered in 9 and 7% of pancreatic cancer and prostate cancer samples, respectively [63]. The gene discussed is ATM; the disease is prostate carcinoma.